Cutting Edge Information, May 2009, Pages: 104
required of primary investigators, by phase
-Percentage of companies with investigator compensation limits in place
-Average number of total site fees by phase
-Average number of investigators per site
Cutting Edge Information, Sep 2009, Pages: 219
: small, mid-size, large, biotech, pharma (average), medical device.
- Compensation methods - flat fee, hourly rate, or a combination of both
- Compensation methods, by percentage, for pharma average and
Cutting Edge Information, April 2009, Pages: 141
compensation data for primary care and specialty/hospital reps and district managers and regional managers across the performance spectrum. Executive Summary
- Methodology and Definitions
- Profiled Companies
Datamonitor, Dec 2008, Pages: 267
vaccine technologies and favourable legislation have brought vaccines back into the main focus of pharmaceutical and biotech companies.
Scope
- Market overview with current market assessment in terms of
ICON Group International, June 2007, Pages: 394
ExecutiveReport on Strategies in Italy How to Strategically Evaluate Italy
Perhaps the most efficient way of evaluating Italy is to consider key dimensions which themselves are composites of
ICON Group International, June 2007, Pages: 386
ExecutiveReport on Strategies in Czech Republic How to Strategically Evaluate Czech Republic
Perhaps the most efficient way of evaluating Czech Republic is to consider key dimensions which
